Patents by Inventor Eran Eilat
Eran Eilat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230316574Abstract: There is provided a method of matching features depicted in images, comprising: detecting a first object depicted in a first image, projecting a first epipolar line, from the first object of the first image, to a second image, selecting second objects along the first epipolar line of the second image, projecting second epipolar lines, from the second objects of the second image, to a third image, projecting a third epipolar line from the first object of the first image to the third image, identifying on the third image, a third object along an intersection of the third epipolar line and a certain second epipolar line of the second epipolar lines, and generating an indication of the first object depicted in first image and the third object depicted in the third image as matches of a same physical object.Type: ApplicationFiled: March 29, 2022Publication date: October 5, 2023Applicant: Percepto Robotics LtdInventors: Eran EILAT, Yekutiel KATZ, Ovadya MENADEVA
-
Publication number: 20230079291Abstract: The present invention provides a method, wherein the method classifies a subject as suffering from dry eye, the method consisting of: a. obtaining demographic data, consisting of the age and gender of the subject; b. obtaining a tear sample from the patient, and determining the level of human serum albumin; c. from the determined level of human serum albumin, assigning a score for the determined amount of human serum albumin; and d. from the assigned score, calculating a cutoff probability score, according to the following equation: exp ? ( - 0.6491 - 1.1142 * Albumin ) 1 + exp ? ( - 0.6491 - 1.1142 * Albumin ) wherein the subject has dry eye, if the calculated cutoff probability score is from 50% to 60%.Type: ApplicationFiled: November 11, 2022Publication date: March 16, 2023Inventors: Amos SOMMER, Ouriel FAKTOR, Eran EILAT
-
Patent number: 11499980Abstract: The present invention provides a method, wherein the method classifies a subject as suffering from dry eye, the method consisting of: a. obtaining demographic data, consisting of the age and gender of the subject; b. obtaining a tear sample from the patient, and determining the level of human serum albumin; c. from the determined level of human serum albumin, assigning a score for the determined amount of human serum albumin; and d. from the assigned score, calculating a cutoff probability score, according to the following equation: exp ( - 0.6491 - 1.1142 * Albumin ) 1 + exp ( - 0.6491 - 1.1142 * Albumin ) wherein the subject has dry eye, if the calculated cutoff probability score is from 50% to 60%.Type: GrantFiled: January 3, 2020Date of Patent: November 15, 2022Assignee: Diagnostear, Ltd.Inventors: Amos Sommer, Ouriel Faktor, Eran Eilat
-
Publication number: 20210283052Abstract: The present invention provides a pH dependent vaginal composition delivering a therapeutically effective amount of at least one active essentially at a pH above 4.5. The composition provides a diagnostic visual pH indication of the presence of vulvovaginitis at pH above 4.5. In the absence of such indication, the treatment may be discontinued. Another visual signal is the retrieval of the unchanged composition, which also points to a normal pH at or below 4.5 and absence of vulvovaginitis.Type: ApplicationFiled: April 5, 2021Publication date: September 16, 2021Applicant: EVE PHARMA LTD.Inventors: Eran Eilat, Stephen Cherkez
-
Patent number: 11020542Abstract: A process and a nebulizer for dispensing a consecutively dose of medicament in the form of a mist, comprising: an energy source (ES), an air-conditioning volume, an air outlet fluidity connected to the air-containing volume, an air actuator adapted to release a flow of compressed air through the air outlet at such time as a predetermined ES pressure has been reached in the volume and at least two valve means in communication with the air actuator. The compressed air is released at a predetermined pressure of about 20 to about 100 psig. The valve means controls the actuation of the air actuator such that when a medication is nebulized, a mist distribution of a medication is formed having droplets size in the range of approximately 1? to approximately 7? which inhaled by a user at a set of predetermined intervals.Type: GrantFiled: July 3, 2014Date of Patent: June 1, 2021Assignee: Sanara Tech Ltd.Inventors: Eran Eilat, Joshua Altman
-
Patent number: 10987306Abstract: The present invention provides a pH dependent vaginal composition delivering a therapeutically effective amount of at least one active essentially at a pH above 4.5. The composition provides a diagnostic visual pH indication of the presence of vulvovaginitis at pH above 4.5. In the absence of such indication, the treatment may be discontinued. Another visual signal is the retrieval of the unchanged composition, which also points to a normal pH at or below 4.5 and absence of vulvovaginitis.Type: GrantFiled: November 14, 2017Date of Patent: April 27, 2021Assignee: Eve Pharma Ltd.Inventors: Eran Eilat, Stephen Cherkez
-
Patent number: 10758689Abstract: A process and a metered dose inhaler, comprising: an air actuator comprising at least one inlet of liquefied gas (LG), at least one air outlet, at least one first LG-expanding volume and at least one second air-containing volume, the first and second volumes are effectively separated by means of a LG-blocking member; a container with an LG source; said container is in a fluid connection with said LG-expanding volume via the at least one LG inlet; The air actuator is facilitating a metered dose airflow by allowing the expansion of said LG in said at least one LG-expanding volume from its condensed liquid phase to its expanded gas phase. The expansion of said LG facilitates the compression of the air within said at least one air-containing volume, such that a metered dose LG-free air flow is inhalable via at least one air outlet.Type: GrantFiled: July 3, 2014Date of Patent: September 1, 2020Assignee: Sanara Tech Ltd.Inventors: Eran Eilat, Joshua Altman
-
Publication number: 20200141945Abstract: The present invention provides a method, wherein the method classifies a subject as suffering from dry eye, the method consisting of: a. obtaining demographic data, consisting of the age and gender of the subject; b. obtaining a tear sample from the patient, and determining the level of human serum albumin; c. from the determined level of human serum albumin, assigning a score for the determined amount of human serum albumin; and d. from the assigned score, calculating a cutoff probability score, according to the following equation: exp ( - 0.6491 - 1.1142 * Albumin ) 1 + exp ( - 0.6491 - 1.1142 * Albumin ) wherein the subject has dry eye, if the calculated cutoff probability score is from 50% to 60%.Type: ApplicationFiled: January 3, 2020Publication date: May 7, 2020Inventors: Amos Sommer, Ouriel Faktor, Eran Eilat
-
Patent number: 10527628Abstract: The present invention provides a method, wherein the method classifies a subject as suffering from dry eye, the method consisting of: a. obtaining demographic data, consisting of the age and gender of the subject; b. obtaining a tear sample from the patient, and determining the level of human serum albumin; c. from the determined level of human serum albumin, assigning a score for the determined amount of human serum albumin; and d. from the assigned score, calculating a cutoff probability score, according to the following equation: wherein the subject has dry eye, if the calculated cutoff probability score is from 50% to 60%. exp ? ( - 0.6491 - 1.1142 * Albumin ) 1 + exp ? ( - 0.6491 - 1.Type: GrantFiled: May 2, 2016Date of Patent: January 7, 2020Assignee: Diagnostear, Ltd.Inventors: Amos Sommer, Ouriel Faktor, Eran Eilat
-
Publication number: 20190302028Abstract: In one embodiment, the present invention is a method for diagnosing Dry Eye Syndrome by quantifying an amount of at least two markers in a tear sample collected from a subject, wherein the at least two markers are selected from the group consisting of: Human Serum Albumin (HSA), mucin, lactoferrin, and lysozyme. In some embodiments, the method is a multi-assay test.Type: ApplicationFiled: January 13, 2017Publication date: October 3, 2019Inventors: Amos Sommera, Ouriel Faktor, Eran Eilat
-
Publication number: 20190212342Abstract: The present invention provides a method, wherein the method classifies a subject as suffering from dry eye, the method consisting of: a. obtaining demographic data, consisting of the age and gender of the subject; b. obtaining a tear sample from the patient, and determining the level of human serum albumin; c. from the determined level of human serum albumin, assigning a score for the determined amount of human serum albumin; and d. from the assigned score, calculating a cutoff probability score, according to the following equation: wherein the subject has dry eye, if the calculated cutoff probability score is from 50% to 60%. exp ? ( - 0.6491 - 1.1142 * Albumin ) 1 + exp ? ( - 0.6491 - 1.Type: ApplicationFiled: May 2, 2016Publication date: July 11, 2019Inventors: Amos Sommer, Ouriel Faktor, Eran Eilat
-
Publication number: 20190051033Abstract: The disclosure relates to systems and methods for differentiating for a user, closer objects from other objects by reducing the radiation reflection of objects beyond a certain distance, to below the detection limit of the sensor used to detect the reflection.Type: ApplicationFiled: February 22, 2017Publication date: February 14, 2019Applicant: SUPERB REALITY LTD.Inventor: Eran Eilat
-
Publication number: 20180344743Abstract: A topical anorectal or genital composition includes at least one film forming ingredient; at least one surfactant; at least one non-polar volatile siloxane solvent; at least 15% (w/w) water; and a therapeutically effective concentration of at least one pharmaceutical agent, wherein the composition is sufficiently designed to dry within 60 seconds after application to the anorectal or genital surface to form a dried composition, and wherein the dried composition forms: a flexible film, wherein the flexible film closely follows irregularities of the body surface as well as movement of the body surface, and (ii) a durable film, wherein the durable film does not crack or flake off and remains intact for more than 12 hours giving release of the pharmaceutical agent for an extended period of time.Type: ApplicationFiled: August 10, 2018Publication date: December 6, 2018Inventors: Evgenia Lozinsky, Eran Eilat
-
Patent number: 10085995Abstract: A topical anorectal composition includes trimethylsiloxysilicate; at least one surfactant selected from the group consisting of sodium lauryl sulfate, alkyl- and alkoxy-dimethicone copolyol, polysorbate and a combination thereof; a non-polar volatile siloxane solvent; at least 15% (w/w) water, and a pharmaceutical agent selected from the group consisting of pramoxine, phenylephrine, hydrocortisone, salicylic acid, nitroglycerine, sildenafil, or their salts and combinations thereof, wherein the composition is sufficiently designed to dry within 60 seconds after application to the anorectal mucosa to form a dried composition, and wherein the dried composition forms: a flexible film, wherein the flexible film closely follows irregularities of the body surface as well as movement of the body surface, and (ii) a durable film, wherein the durable film does not crack or flake off and remains intact for more than 12 hours giving release of the pharmaceutical agent for an extended period of time.Type: GrantFiled: June 16, 2015Date of Patent: October 2, 2018Assignee: PeriTech Pharma Ltd.Inventors: Evgenia Lozinsky, Eran Eilat
-
Patent number: 10085994Abstract: A topical composition includes at least one film forming ingredient; at least one surfactant; at least one non-polar volatile siloxane solvent; at least 15% (w/w) water; and a therapeutically effective concentration of at least one pharmaceutical agent, wherein the composition is sufficiently designed to dry within 60 seconds after application to a body surface to form a dried composition, and wherein the dried composition forms: a flexible film, wherein the flexible film closely follows irregularities of the body surface as well as movement of the body surface, and (ii) a durable film, wherein the durable film does not crack or flake off and remains intact for more than 12 hours giving release of the pharmaceutical agent for an extended period of time.Type: GrantFiled: March 10, 2014Date of Patent: October 2, 2018Assignee: PeriTech Pharma Ltd.Inventors: Evgenia Lozinsky, Eran Eilat
-
Publication number: 20180093069Abstract: The present invention discloses a catheter tip having a main longitudinal axis with a tapered distal portion having an enveloping external wall defining an inner space; wherein the thickness of said wall is radially asymmetric with respect to said axis. The present invention also discloses a catheter tip having a main longitudinal axis having a tapered distal portion comprising an enveloping external wall defining an inner space; wherein said tip is provided with at least one first small aperture and at least one second large aperture, said apertures are located approximately opposite each other.Type: ApplicationFiled: October 3, 2017Publication date: April 5, 2018Applicant: CATHAWAY MEDICAL (2012) LTD.Inventors: Eyal BRESSLER, Eran EILAT
-
Publication number: 20180064647Abstract: The present invention provides a pH dependent vaginal composition delivering a therapeutically effective amount of at least one active essentially at a pH above 4.5. The composition provides a diagnostic visual pH indication of the presence of vulvovaginitis at pH above 4.5. In the absence of such indication, the treatment may be discontinued. Another visual signal is the retrieval of the unchanged composition, which also points to a normal pH at or below 4.5 and absence of vulvovaginitis.Type: ApplicationFiled: November 14, 2017Publication date: March 8, 2018Inventors: Eran Eilat, Stephen Cherkez
-
Publication number: 20170161958Abstract: The disclosure relates to augmented reality assisted navigation. More particularly, the disclosure relates to the use of augmented reality display in providing object-based navigation guidance.Type: ApplicationFiled: November 29, 2016Publication date: June 8, 2017Applicant: SUPERB REALITY LTD.Inventor: Eran EILAT
-
Publication number: 20170128677Abstract: A process and a nebulizer for dispensing a consecutively dose of medicament in the form of a mist, comprising: an energy source (ES), an air-conditioning volume, an air outlet fluidity connected to the air-containing volume, an air actuator adapted to release a flow of compressed air through the air outlet at such time as a predetermined ES pressure has been reached in the volume and at least two valve means in communication with the air actuator. The compressed air is released at a predetermined pressure of about 20 to about 100 psig. The valve means controls the actuation of the air actuator such that when a medication is nebulized, a mist distribution of a medication is formed having droplets size in the range of approximately 1? to approximately 7? which inhaled by a user at a set of predetermined intervals.Type: ApplicationFiled: July 3, 2014Publication date: May 11, 2017Inventors: Eran Eilat, Joshua Altman
-
Publication number: 20170097685Abstract: A method for computer vision based control of a fixture including identifying in an image a user indicating at the fixture and based on the identification of a user indicating at the fixture causing a processor associated with the fixture to generate an identifying signal. The method may include causing a control device to assign the fixture to a group of fixtures based on the identifying signal.Type: ApplicationFiled: April 28, 2015Publication date: April 6, 2017Inventors: MEIR MORAG, ERAN EILAT, RON SOKOLOVSKY